United States
Germany
Japan
United Kingdom
China
3' UTR clone of serpin peptidase inhibitor clade A (alpha-1 antiproteinase antitrypsin) member 1 (SERPINA1) transcript variant 8 for miRNA target validation
| Vector | pMirTarget |
| Species | Human |
| Transfection Reporter | RFP |
| Assay Reporter | Luciferase |
Products
3' UTR clone of serpin peptidase inhibitor clade A (alpha-1 antiproteinase antitrypsin) member 1 (SERPINA1) transcript variant 6 for miRNA target validation
| Vector | pMirTarget |
| Species | Human |
| Transfection Reporter | RFP |
| Assay Reporter | Luciferase |
3' UTR clone of serpin peptidase inhibitor clade A (alpha-1 antiproteinase antitrypsin) member 1 (SERPINA1) transcript variant 4 for miRNA target validation
| Vector | pMirTarget |
| Species | Human |
| Transfection Reporter | RFP |
| Assay Reporter | Luciferase |
3' UTR clone of serpin peptidase inhibitor clade A (alpha-1 antiproteinase antitrypsin) member 1 (SERPINA1) transcript variant 7 for miRNA target validation
| Vector | pMirTarget |
| Species | Human |
| Transfection Reporter | RFP |
| Assay Reporter | Luciferase |
3' UTR clone of serpin peptidase inhibitor clade A (alpha-1 antiproteinase antitrypsin) member 1 (SERPINA1) transcript variant 3 for miRNA target validation
| Vector | pMirTarget |
| Species | Human |
| Transfection Reporter | RFP |
| Assay Reporter | Luciferase |
Serpina1 (Rat) - 3 unique 27mer siRNA duplexes - 2 nmol each
| Purity | HPLC purified |
| Number of Transfections | Approximately 330 transfections/2nmol in 24-well plate under optimized conditions (final conc. 10 nM). |
